The groundbreaking therapy of the medication represents a exciting breakthrough in the handling of the condition. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide402539.livebloggs.com/48807759/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment